Join Jonathan Wingfield, Senior Principal Scientist at AstraZeneca, as he delves into the nuances of drug discovery, discussing the development of a high-throughput mass spectrometry platform. Recorded at Pittcon 2018 in Orlando, this interview offers insights into an innovative technique that accelerates the drug discovery process, bridging the gap from research to patient benefit faster than ever. Wingfield highlights the challenges faced, the solutions crafted, and the future potential of mass spectrometry in reshaping drug discovery. To grasp the full depth of the transformative power of high-throughput mass spectrometry in drug discovery, explore the complete interview here: www.news-medical.net/news/20180518/Developing-a-High-Throughput-Mass-Spectrometry-Platform-for-Drug-Discovery.aspx

Be the first to comment